Cite Filings / ACAD / 0000950170-24-049182

Feed Companies Filings Check

Sign in

DEF 14A

Proxy Statement

ACADIA PHARMACEUTICALS INC Filed 2024-04-26 Acc 0000950170-24-049182

Documents 1

DEF 14A Proxy Statement , acad-20240426.htm

Around this filing

2025-04-25 DEF 14A Proxy Statement
2024-05-03 4 EVP, COO, HEAD OF COMMERCIAL sold 3,477 shares at $16.94 ($58,900)
2024-05-03 4 EVP, CHIEF FINANCIAL OFFICER sold 3,503 shares at $16.94 ($59,341)
2024-05-03 4 PRINCIPAL ACCOUNTING OFFICER sold 1,326 shares at $16.94 ($22,462)
2024-04-26 ARS Annual Report to Security Holders
2024-04-26 DEF 14A Proxy Statement
2023-05-01 DEF 14A Proxy Statement

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)
SEC Structured Data (opens in new tab)

Loading acad-20240426.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…